Polyglutamine expansion and altered gene expression
Polyglutamine expansion and altered gene expression
批准号:
7209810
负责人:
Shi-Hua Li
金额:
$23.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-01 至 2009-02-28
关键词:
AffectBindingBiochemicalBrainCell NucleusCell physiologyCorpus striatum structureCultured CellsDNADRPLA proteinDefectDimerizationDiseaseFunctional disorderGene ExpressionGenesGenetic TranscriptionGlutamineHuntington DiseaseInheritedInvestigationKnock-in MouseMusN-terminalNerve DegenerationNeurodegenerative DisordersNeurologicNeuronsNuclearNuclear InclusionNumbersPhenotypeProcessProtein IsoformsProteinsSpecificitySymptomsTATA BoxTATA-Box Binding ProteinTBP geneTestingToxic effectTranscription Coactivatorhuman Huntingtin proteinimprovedinsightmutantneuropathologypolyglutaminepromotertherapeutic targettranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nine inherited neurodegenerative disorders are caused by an expansion of a polyglutamine tract in the associated disease proteins. Increasing evidence indicates that huntingtin containing an expanded polyglutamine tract accumulates in the nucleus and affects gene expression in Huntington disease (HD). Transcriptional dysregulation may also be the major pathological cause in SCA17 in which polyglutamine expansion is present in the TATA binding protein (TBP). HD and SCA17 show similar neurological phenotypes and neuropathology characterized by neurodegeneration in the striatum and cortex, suggesting that both diseases may share a similar pathological mechanism. Although recent studies have shown that mutant huntingtin binds to the transcriptional factors Sp1 and TAF130, the mechanism by which mutant polyglutamine proteins affect gene expression remains to be investigated. Furthermore, it is unclear how the abnormal interactions between mutant polyglutamine proteins and transcription factors contribute to the disease process. We hypothesize that soluble polyglutamine proteins interfere with gene expression by altering the interactions between transcription factors and their DNA targets before the formation of large nuclear inclusions. To test this hypothesis, we will (1) study how mutant N-terminal huntingtin abnormally binds to Sp1 to affect gene expression, (2) investigate whether polyglutamine expansion causes TBP to abnormally bind to the TATA box and its associated factors, and (3) examine whether polyglutamine expansion causes TBP and huntingtin to abnormally bind to the transcriptional factor TAF130, leading to a common transcriptional defect that may contribute to the similar neuropathology in HD and SCA17. These studies aim to provide insights into the mechanism by which polyglutamine expansion affects gene expression. They will also help identify a therapeutic target for the treatment of polyglutamine diseases
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glial huntingtin and neurodegeneration
-
批准号:9137737
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2015
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine Expansion Length Dependent Pathology
-
批准号:9019181
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2015
-
负责人:Shi-Hua Li
-
依托单位:
Glial huntingtin and neuronal excitotoxicity
-
批准号:8531089
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2009
-
负责人:Shi-Hua Li
-
依托单位:
Glial huntingtin and neuronal excitotoxicity
-
批准号:7927105
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2009
-
负责人:Shi-Hua Li
-
依托单位:
Glial huntingtin and neuronal excitotoxicity
-
批准号:8316226
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2009
-
负责人:Shi-Hua Li
-
依托单位:
Glial huntingtin and neuronal excitotoxicity
-
批准号:7652772
-
项目类别:
-
资助金额:$31.78万
-
财政年份:2009
-
负责人:Shi-Hua Li
-
依托单位:
Glial huntingtin and neuronal excitotoxicity
-
批准号:8127762
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2009
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and altered gene expression
-
批准号:7023761
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and neuropathology
-
批准号:8436245
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and altered gene expression
-
批准号:6776662
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and neuropathology
-
批准号:8044755
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and altered gene expression
-
批准号:6862601
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and neuropathology
-
批准号:7762739
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and neuropathology
-
批准号:8265821
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
Polyglutamine expansion and altered gene expression
-
批准号:7384999
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2004
-
负责人:Shi-Hua Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: